Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Anticoagulants regimen

From: Early hemodynamic performance of the Trifecta™ surgical bioprosthesis aortic valve in Indian patient population: 12 month outcomes of the EVEREST post-market study

Visits Anticoagulant regimen n (%)
Baseline 81/100 (81%)
Pre-discharge 95/100 (95%)
6 Month 87/96 (91%)
12 Month 79/90 (88%)
  1. n = Total number of patients